Peptide-enhanced cellular internalization of proteins in neuroscience

Brain Research Bulletin

Volumn 68, Issue 1-2, 2005, Pages 103-114

  Dietz, Gunnar P H ^a   Bähr, Mathias ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Antennapedia (penetratin); Arginine rich peptide; HIV Tat; Ischemia; Protein delivery; Trojan Horse

Indexed keywords

ACYLTRANSFERASE; ALPHA SYNUCLEIN; ANTENNAPEDIA PROTEIN; ANTHRAX TOXIN; BASIC FIBROBLAST GROWTH FACTOR; BETA GALACTOSIDASE; BETA GLUCURONIDASE; BETA SECRETASE INHIBITOR; BOTULINUM TOXIN A; BRAIN DERIVED NEUROTROPHIC FACTOR; CALPASTATIN; CARRIER PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; DOXORUBICIN; DRUG CARRIER; FRAGILE X MENTAL RETARDATION PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE DEHYDROGENASE; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; LIPOSOME; PARVOVIRUS VECTOR; PENETRATIN; PENICILLIN G; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN BCL 2; PROTEIN BCL XL; SN 50; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SUPEROXIDE DISMUTASE; TRANSACTIVATOR PROTEIN; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL MENINGITIS; BEHAVIOR DISORDER; BIOAVAILABILITY; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL ADHESION; CELL MEMBRANE; CELL TRANSPORT; CONVALESCENCE; ELECTRICITY; ENCEPHALITIS; EXCITOTOXICITY; GENE DELIVERY SYSTEM; HEART MUSCLE ISCHEMIA; HUMAN; HUNTINGTON CHOREA; INFECTION PREVENTION; LONG TERM POTENTIATION; LYSOSOME STORAGE DISEASE; MEDICAL RESEARCH; MOLECULAR MECHANICS; NERVE DEGENERATION; NERVE INJURY; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROSCIENCE; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSPORT; PUBLICATION; SIGNAL TRANSDUCTION; VIRAL GENE THERAPY;

ANIMALS; BLOOD-BRAIN BARRIER; DRUG DELIVERY SYSTEMS; HUMANS; NEUROSCIENCES; PEPTIDE FRAGMENTS; PROTEIN TRANSPORT;

EID: 28144440865     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2005.08.015     Document Type: Article

References (201)

1. M. Aarts, Y. Liu, L. Liu, S. Besshoh, M. Arundine, J.W. Gurd, Y.T. Wang, M.W. Salter, and M. Tymianski Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions Science 298 2002 846 850
2. M.Y. Aksenov, U. Hasselrot, G. Wu, A. Nath, C. Anderson, C.F. Mactutus, and R.M. Booze Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum Brain Res. 987 2003 1 9
3. D. Albani, E. Peverelli, R. Rametta, S. Batelli, L. Veschini, A. Negro, and G. Forloni Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70 FASEB J. 18 2004 1713 1715
4. B. Allinquant, P. Hantraye, P. Mailleux, K. Moya, C. Bouillot, and A. Prochiantz Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro J. Cell Biol. 128 1995 919 927
5. E.G. Argyris, J. Kulkosky, M.E. Meyer, Y. Xu, M. Mukhtar, R.J. Pomerantz, and K.J. Williams The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity Virology 330 2004 481 486
6. T. Asanuma, O. Inanami, K. Tabu, K. Waki, Y. Kon, and M. Kuwabara Protection against malonate-induced ischemic brain injury in rat by a cell-permeable peptidic c-Jun N-terminal kinase inhibitor, (L)-HIV-Tat48-57-PP- JBD20, observed by the apparent diffusion coefficient mapping magnetic resonance imaging method Neurosci. Lett. 359 2004 57 60
7. S. Asoh, I. Ohsawa, T. Mori, K. Katsura, and T. Hiraide Protection against ischemic brain injury by protein therapeutics Proc. Natl. Acad. Sci. U.S.A. 99 2002 17107 17112
8. S. Asoh, T. Ohtsu, and S. Ohta The super anti-apoptotic factor Bcl-xFNK constructed by disturbing intramolecular polar interactions in rat Bcl-xL J. Biol. Chem. 275 2000 37240 37245
9. E.B. Becker, and A. Bonni Cell cycle regulation of neuronal apoptosis in development and disease Prog. Neurobiol. 72 2004 1 25
10. R. Begley, T. Liron, J. Baryza, and D. Mochly-Rosen Biodistribution of intracellularly acting peptides conjugated reversibly to Tat Biochem. Biophys. Res. Commun. 318 2004 949 9454
11. P.N. Bernatchez, P.M. Bauer, J. Yu, J.S. Prendergast, P. He, and W.C. Sessa Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides Proc. Natl. Acad. Sci. U.S.A. 6 2005 761 766
12. J. Bertrand, L.J. McKerracher, Intravitreal injection of C3-05 promotes regeneration after intraorbital microlesion of the optic nerve in adult rat, Abstract Viewer/Itinerary Planner, Society for Neuroscience (2003) Program No. 678.11, Washington, DC.
13. J. Bertrand, M.J. Winton, N. Rodriguez-Hernandez, R.B. Campenot, and L. McKerracher Application of Rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats J. Neurosci. 25 2005 1113 1121
14. H. Binder, and G. Lindblom A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers Biophys. J. 87 2004 332 343
15. E. Bloch-Gallego, I. Le Roux, A.H. Joliot, M. Volovitch, C.E. Henderson, and A. Prochiantz Antennapedia homeobox peptide enhances growth and branching of embryonic chicken motoneurons in vitro J. Cell Biol. 120 1993 485 492
16. S. Blum, and P.K. Dash A cell-permeable phospholipase Cgamma1-binding peptide transduces neurons and impairs long-term spatial memory Learn. Mem. 11 2004 239 243
17. S.J. Bolton, D.N. Jones, J.G. Darker, D.S. Eggleston, A.J. Hunter, and F.S. Walsh Cellular uptake and spread of the cell-permeable peptide penetratin in adult rat brain Eur. J. Neurosci. 12 2000 2847 2855
18. T. Borsello, P.G. Clarke, L. Hirt, A. Vercelli, M. Repici, D.F. Schorderet, J. Bogousslavsky, and C. Bonny A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia Nat. Med. 9 2003 1180 1186
19. M.S. Bowers, K. McFarland, R.W. Lake, Y.K. Peterson, C.C. Lapish, M.L. Gregory, S.M. Lanier, and P.W. Kalivas Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking Neuron 42 2004 269 281
20. D.A. Brown, and E. London Structure and function of sphingolipid- and cholesterol-rich membrane rafts J. Biol. Chem. 275 2000 17221 17224
21. A.J. Bruce-Keller, A. Chauhan, F.O. Dimayuga, J. Gee, J.N. Keller, and A. Nath Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain J. Neurosci. 23 2003 8417 8422
22. I. Caille, B. Allinquant, E. Dupont, C. Bouillot, A. Langer, U. Muller, and A. Prochiantz Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone Development 131 2004 2173 2181 (Epub 2004 Apr 08)
23. G. Cao, W. Pei, H. Ge, Q. Liang, and Y. Luo In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis J. Neurosci. 22 2002 5423 5431
24. N.J. Caron, S.P. Quenneville, and J.P. Tremblay Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins Biochem. Biophys. Res. Commun. 319 2004 12 20
25. S.M. Cashman, D.J. Morris, and R. Kumar-Singh Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo Mol. Ther. 8 2003 130 142
26. S.M. Cashman, S.L. Sadowski, D.J. Morris, J. Frederick, and R. Kumar-Singh Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors-implications for gene therapy Mol. Ther. 6 2002 813 823
27. W.P. Chang, G. Koelsch, S. Wong, D. Downs, and H. Da In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors J. Neurochem. 89 2004 1409 1416
28. M. Chang, L. Zhang, J.P. Tam, E. Sanders-Bush, and Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells J. Biol. Chem. 275 2000 7021 7029
29. L. Chatelin, M. Volovitch, A.H. Joliot, F. Perez, and A. Prochiantz Transcription factor hoxa-5 is taken up by cells in culture and conveyed to their nuclei Mech. Dev. 55 1996 111 117
30. B. Chaubey, S. Tripathi, S. Ganguly, D. Harris, R.A. Casale, and V.N. Pandey A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties Virology 331 2005 418 428
31. A. Chauhan, J. Turchan, C. Pocernich, A. Bruce-Keller, S. Roth, D.A. Butterfield, E.O. Major, and A. Nath Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport J. Biol. Chem. 278 2003 13512 13519
32. Y.N. Chen, S.K. Sharma, T.M. Ramsey, L. Jiang, M.S. Martin, K. Baker, P.D. Adams, K.W. Bair, and W.G. Kaelin Jr. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists Proc. Natl. Acad. Sci. U.S.A. 96 1999 4325 4329
33. M. Chen, D.J. Won, S. Krajewski, and R.A. Gottlieb Calpain and mitochondria in ischemia/reperfusion injury J. Biol. Chem. 277 2002 29181 29186
34. S. Console, C. Marty, C. Garcia-Echeverria, R. Schwendener, and K. Ballmer-Hofer Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans J. Biol. Chem. 278 2003 35109 35114
35. J.T. Coyle, and R. Schwarcz Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea Nature 263 1976 244 246
36. P. Curnow, H. Mellor, D.J. Stephens, M. Lorch, and P.J. Booth Lipids, rafts and traffic: chapter 19 - translocation of the cell-penetrating Tat peptide across artificial bilayers and into living cells Biochem. Soc. Symp. 2005 199 209
37. V. Del Gaizo, and R. Mark Payne A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta Mol. Ther. 7 2003 720 730
38. D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing, and A. Prochiantz Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent J. Biol. Chem. 271 1996 18188 18193
39. D. Derossi, G. Chassaing, and A. Prochiantz Trojan peptides: the penetratin system for intracellular delivery Trends Cell Biol. 8 1998 84 87
40. D. Derossi, A.H. Joliot, G. Chassaing, and A. Prochiantz The third helix of the Antennapedia homeodomain translocates through biological membranes J. Biol. Chem. 269 1994 10444 10450
41. R. Diem, N. Taheri, G.P.H. Dietz, A. Kuhnert, K. Maier, M.B. Sättler, I. Gadjanski, D. Merkler, M. Bähr, HIV-Tat-mediated Bcl-xL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis. Neurobiol. Disease, in press (available online 8 April 2005).
42. G.P.H. Dietz, E. Kilic, and M. Bähr Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction Mol. Cell Neurosci. 21 2002 29 37
43. G.P.H. Dietz, E. Kilic, and M. Bähr Delivery of bioactive molecules into the cell: the Trojan Horse approach Mol. Cell Neurosci. 27 2004 85 131
44. G.P.H. Dietz, M. Schott, M. Labes, and M. Bähr Expression of the protein inhibitor of nitric oxide synthase in the adult rat retina before and after optic nerve lesion Brain Res. Mol. Brain Res. 136 2005 118 124
45. G. Dom, C. Shaw-Jackson, C. Matis, O. Bouffioux, J.J. Picard, A. Prochiantz, M.P. Mingeot-Leclercq, R. Brasseur, and R. Rezsohazy Cellular uptake of Antennapedia penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation Nucleic Acids Res. 31 2003 556 561
46. W.R. Dostmann, M.S. Taylor, C.K. Nickl, J.E. Brayden, R. Frank, and W.J. Tegge Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation Proc. Natl. Acad. Sci. U.S.A. 97 2000 14772 14777
47. G. Drin, S. Cottin, E. Blanc, A.R. Rees, and J. Temsamani Studies on the internalisation mechanism of cationic cell-penetrating peptides J. Biol. Chem. 278 2003 31192 31201
48. S. Ebert, G.P.H. Dietz, T.J. Mitchell, U. Michel, M. Bähr, and R. Nau Limited protection of Tat-Bcl-X(L) against pneumolysin-induced neuronal cell death Neurosci. Lett. 384 2005 349 353
49. S.S. Elliger, C.A. Elliger, C. Lang, and G.L. Watson Enhanced secretion and uptake of beta-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice Mol. Ther. 5 2002 617 626
50. G. Elliott, and P. O'Hare Intercellular trafficking and protein delivery by a herpesvirus structural protein Cell 88 1997 223 233
51. J. Embury, D. Klein, A. Pileggi, M. Ribeiro, and S. Jayaraman Proteins linked to a protein transduction domain efficiently transduce pancreatic islets Diabetes 50 2001 1706 1713
52. E.A. Eugenin, G. Dyer, T.M. Calderon, and J.W. Berman HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS Glia 1 2004 1
53. W.S. Eum, D. Won Kim, I. Koo Hwang, K.Y. Yoo, and T.C. Kang In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult Free Radic. Biol. Med. 37 2004 1656 1669
54. S. Fawell, J. Seery, Y. Daikh, C. Moore, L.L. Chen, B. Pepinsky, and J. Barsoum Tat-mediated delivery of heterologous proteins into cells Proc. Natl. Acad. Sci. U.S.A. 91 1994 664 668
55. R. Fischer, K. Köhler, M. Fotin-Mleczek, and R. Brock A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides J. Biol. Chem. 279 2004 12625 12635 (Epub 2004 Jan 05)
56. P.M. Fischer, N.Z. Zhelev, S. Wang, J.E. Melville, R. Fahraeus, and D.P. Lane Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin J. Pept. Res. 55 2000 163 172
57. A. Fittipaldi, A. Ferrari, M. Zoppe, C. Arcangeli, V. Pellegrini, F. Beltram, and M. Giacca Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 tat fusion proteins J. Biol. Chem. 278 2003 34141 34149
58. C. Foerg, U. Ziegler, J. Fernandez-Carneado, E. Giralt, R. Rennert, A.G. Beck-Sickinger, and H.P. Merkle Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape Biochemistry 44 2005 72 81
59. J.W. Francis, E. Bastia, C.C. Matthews, D.A. Parks, M.A. Schwarzschild, R.H. Brown Jr., and P.S. Fishman Tetanus toxin fragment C as a vector to enhance delivery of proteins to the CNS Brain Res. 1011 2004 7 13
60. J.W. Francis, R.H. Brown Jr., D. Figueiredo, M.P. Remington, O. Castillo, M.A. Schwarzschild, P.S. Fishman, J.R. Murphy, and J.C. vanderSpek Enhancement of diphtheria toxin potency by replacement of the receptor binding domain with tetanus toxin C-fragment: a potential vector for delivering heterologous proteins to neurons J. Neurochem. 74 2000 2528 2536
61. J.W. Francis, D. Figueiredo, J.C. vanderSpek, L.M. Ayala, and Y.S. Kim A survival motor neuron:tetanus toxin fragment C fusion protein for the targeted delivery of SMN protein to neurons Brain Res. 995 2004 84 96
62. J.W. Francis, B.A. Hosler, R.H. Brown Jr., and P.S. Fishman CuZn superoxide dismutase (SOD-1):tetanus toxin fragment C hybrid protein for targeted delivery of SOD-1 to neuronal cells J. Biol. Chem. 270 1995 15434 15442
63. M.M. Fretz, G.A. Koning, E. Mastrobattista, W. Jiskoot, and G. Storm OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis Biochim. Biophys. Acta 1665 2004 48 56
64. A.L. Fu, Q. Li, Z.H. Dong, S.J. Huang, Y.X. Wang, and M.J. Sun Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase Neurosci. Lett. 368 2004 258 262
65. S. Fujihara, E. Jaffray, S.N. Farrow, A.G. Rossi, C. Haslett, and R.T. Hay Inhibition of NF-kappa B by a cell permeable form of I kappa B alpha induces apoptosis in eosinophils Biochem. Biophys. Res. Commun. 326 2005 632 637
66. T. Fujiwara, T. Yamamori, and K. Akagawa Suppression of transmitter release by Tat HPC-1/syntaxin 1A fusion protein Biochim. Biophys. Acta 1539 2001 225 232
67. S. Futaki Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms Int. J. Pharm. 245 2002 1 7
68. S. Futaki, W. Ohashi, T. Suzuki, M. Niwa, S. Tanaka, K. Ueda, H. Harashima, and Y. Sugiura Stearylated arginine-rich peptides: a new class of transfection systems Bioconjug. Chem. 12 2001 1005 1011
69. S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 276 2001 5836 5840
70. E. Ghibaudi, B. Boscolo, G. Inserra, E. Laurenti, S. Traversa, L. Barbero, and R.P. Ferrari The interaction of the cell-penetrating peptide penetratin with heparin, heparansulfates and phospholipid vesicles investigated by ESR spectroscopy J. Pept. Sci. 11 7 2005 401 409
71. I. Green, R. Christison, C.J. Voyce, K.R. Bundell, and M.A. Lindsay Protein transduction domains: are they delivering? Trends Pharmacol. Sci. 24 2003 213 215
72. M. Guizzetti, F. Bordi, F.J. Dieguez-acuna, A. Vitalone, F. Madia, J.S. Woods, and L.G. Costa Nuclear factor kappab activation by muscarinic receptors in astroglial cells: effect of ethanol Neuroscience 120 2003 941 950
73. S. Gunaseelan, O. Debrah, L. Wan, M.J. Leibowitz, A.B. Rabson, S. Stein, and P.J. Sinko Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay Bioconjug. Chem. 15 2004 1322 1333
74. H. Hall, E.J. Williams, S.E. Moore, F.S. Walsh, A. Prochiantz, and P. Doherty Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide Curr. Biol. 6 1996 580 587
75. M. Hällbrink, J. Oehlke, G. Papsdorf, and M. Bienert Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentration Biochim. Biophys. Acta 1667 2004 222 228
76. X. Han, J.H. Bushweller, D.S. Cafiso, and L.K. Tamm Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin Nat. Struct. Biol. 8 2001 715 720
77. K. Hashimoto, S.K. Joshi, and P.A. Koni A conditional null allele of the major histocompatibility IA-beta chain gene Genesis 32 2002 152 153
78. N.J. Haughey, and M.P. Mattson Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120 J. Acquir. Immune Defic. Syndr. 31 2002 S55 S61
79. D.Y. He, A.J. Vagts, R. Yaka, and D. Ron Ethanol induces gene expression via nuclear compartmentalization of receptor for activated C kinase 1 Mol. Pharmacol. 62 2002 272 280
80. E.P. Holinger, T. Chittenden, and R.J. Lutz Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases J. Biol. Chem. 274 1999 13298 13304
81. C. Ibanez, C. Blanes-Mira, G. Fernandez-Ballester, R. Planells-Cases, and A. Ferrer-Montiel Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation FEBS Lett. 578 2004 121 127
82. T. Jiang, E.S. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings, and R.Y. Tsien Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Natl. Acad. Sci. U.S.A. 101 2004 17867 17872
83. D. Jo, A. Nashabi, C. Doxsee, Q. Lin, D. Unutmaz, J. Chen, and H.E. Ruley Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase Nat. Biotechnol. 19 2001 929 933
84. A. Joliot, C. Pernelle, H. Deagostini-Bazin, and A. Prochiantz Antennapedia homeobox peptide regulates neural morphogenesis Proc. Natl. Acad. Sci. U.S.A. 88 1991 1864 1868
85. A. Joliot, and A. Prochiantz Transduction peptides, from technology to physiology Nat. Rev.: Mol. Cell Biol. 6 3 2004
86. A.H. Joliot, A. Triller, M. Volovitch, C. Pernelle, and A. Prochiantz Alpha-2, 8-Polysialic acid is the neuronal surface receptor of antennapedia homeobox peptide New Biol. 3 1991 1121 1134
87. S.K. Joshi, K. Hashimoto, and P.A. Koni Induced DNA recombination by Cre recombinase protein transduction Genesis 33 2002 48 54
88. C. Kardinal, B. Konkol, H. Lin, M. Eulitz, E.K. Schmidt, Z. Estrov, M. Talpaz, R.B. Arlinghaus, and S.M. Feller Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes Blood 98 2001 1773 1781
89. C. Kardinal, B. Konkol, A. Schulz, G. Posern, and H. Lin Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients FASEB J. 14 2000 1529 1538
90. V. Kasim, M. Miyagishi, and K. Taira Control of siRNA expression utilizing Cre-loxP recombination system Nucleic Acids Res. Suppl. 3 2003 255 256
91. Y. Katterle, B.H. Brandt, S.F. Dowdy, B. Niggemann, K.S. Zanker, and T. Dittmar Antitumour effects of PLC-gamma1-(SH2)2-TAT fusion proteins on EGFR/c-erbB-2-positive breast cancer cells Br. J. Cancer 90 2004 230 235
92. K. Kazama, J. Anrather, P. Zhou, H. Girouard, K. Frys, T.A. Milner, and C. Iadecola Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals Circ. Res. 95 2004 1019 1026
93. B.R. Kelemen, K. Hsiao, and S.A. Goueli Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides J. Biol. Chem. 277 2002 8741 8748
94. L is protective after middle cerebral artery occlusion in mice Ann. Neurol. 52 2002 617 622
95. Ü. Kilic, E. Kilic, G.P.H. Dietz, and M. Bähr Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice Stroke 34 2003 1304 1310
96. Ü. Kilic, E. Kilic, G.P.H. Dietz, and M. Bähr The TAT protein transduction domain enhances the neuroprotective effect of GDNF after optic nerve transection Neurodegenerative Dis. 1 2004 44 49
97. B.O. Kim, Y. Liu, Y. Ruan, Z.C. Xu, L. Schantz, and J.J. He Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline Am. J. Pathol. 162 2003 1693 1707
98. D. Klein, M.M. Ribeiro, V. Mendoza, S. Jayaraman, and N.S. Kenyon Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets Biochem. Biophys. Res. Commun. 323 2004 473 478
99. A. Knight, J. Carvajal, H. Schneider, C. Coutelle, S. Chamberlain, and N. Fairweather Non-viral neuronal gene delivery mediated by the HC fragment of tetanus toxin Eur. J. Biochem. 259 1999 762 769
100. A. Kretz, W.A. Wybranietz, S. Hermening, U.M. Lauer, and S. Isenmann HSV-1 VP22 augments adenoviral gene transfer to CNS neurons in the retina and striatum in vivo Mol. Ther. 7 2003 659 669
101. F. Kuhnel, B. Schulte, T. Wirth, N. Woller, S. Schafers, L. Zender, M. Manns, and S. Kubicka Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors J. Virol. 78 2004 13743 13754
102. I. Le Roux, A.H. Joliot, E. Bloch-Gallego, A. Prochiantz, and M. Volovitch Neurotrophic activity of the Antennapedia homeodomain depends on its specific DNA-binding properties Proc. Natl. Acad. Sci. U.S.A. 90 1993 9120 9124
103. Y. Li, Y. Mao, R.V. Rosal, R.D. Dinnen, A.C. Williams, P.W. Brandt-Rauf, and R.L. Fine Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells Int. J. Cancer 11 2005 11
104. L. Li, R.M. Thomas, H. Suzuki, J.K. De Brabander, X. Wang, and P.G. Harran A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death Science 305 2004 1471 1474
105. Q. Lin, D. Jo, K.D. Grebre-Amlak, and H.E. Ruley Enhanced cell-permeant Cre protein for site-specific recombination in cultured cells BMC Biotechnol. 4 2004 25
106. T. Lindsten, W.X. Zong, and C.B. Thompson Defining the role of the bcl-2 family of proteins in the nervous system Neuroscientist 11 2005 10 15
107. X.H. Liu, J.C. Castelli, and R.J. Youle Receptor-mediated uptake of an extracellular Bcl-x(L) fusion protein inhibits apoptosis Proc. Natl. Acad. Sci. U.S.A. 96 1999 9563 9567
108. X.H. Liu, R.J. Collier, and R.J. Youle Inhibition of axotomy-induced neuronal apoptosis by extracellular delivery of a Bcl-XL fusion protein J. Biol. Chem. 276 2001 46326 46332
109. Y. Liu, M. Jones, C.M. Hingtgen, G. Bu, N. Laribee, R.E. Tanzi, R.D. Moir, A. Nath, and J.J. He Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands Nat. Med. 6 2000 1380 1387
110. N.Q. Liu, A.S. Lossinsky, W. Popik, X. Li, and C. Gujuluva Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway J. Virol. 76 2002 6689 6700
111. J.C. Mai, H. Shen, S.C. Watkins, T. Cheng, and P.D. Robbins Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate J. Biol. Chem. 277 2002 30208 30218
112. M. Matsushita, H. Noguchi, Y.F. Lu, K. Tomizawa, H. Michiue, S.T. Li, K. Hirose, S. Bonner-Weir, and H. Matsui Photo-acceleration of protein release from endosome in the protein transduction system FEBS Lett. 572 2004 221 226
113. M. Matsushita, K. Tomizawa, A. Moriwaki, S.T. Li, H. Terada, and H. Matsui A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation J. Neurosci. 21 2001 6000 6007
114. M. Mazel, P. Clair, C. Rousselle, P. Vidal, J.M. Scherrmann, D. Mathieu, and J. Temsamani Doxorubicin-peptide conjugates overcome multidrug resistance Anticancer Drugs 12 2001 107 116
115. M.A. Melan, and G. Sluder Redistribution and differential extraction of soluble proteins in permeabilized cultured cells. Implications for immunofluorescence microscopy J. Cell Sci. 101 1992 731 743
116. 2-terminal of influenza virus hemagglutinin-2 subunit peptides enhance the anti-tumor potency of poly-arginine-mediated p53 protein transduction J. Biol. Chem. 280 9 2005 8285 8289
117. D. Michod, J.Y. Yang, J. Chen, C. Bonny, and C. Widmann A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells Oncogene 23 2004 8971 8978
118. T. Minko, S.S. Dharap, and A.T. Fabbricatore Enhancing the efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular defense Cancer Detect. Prev. 27 2003 193 202
119. M.C. Morris, J. Depollier, J. Mery, F. Heitz, and G. Divita A peptide carrier for the delivery of biologically active proteins into mammalian cells Nat. Biotechnol. 19 2001 1173 1176
120. J.A. Moss, A. Lillo, Y.S. Kim, C. Gao, H. Ditzel, and K.D. Janda A dimerization "switch" in the internalization mechanism of a cell-penetrating Peptide J. Am. Chem. Soc. 127 2005 538 539
121. H.M. Moulton, M.C. Hase, K.M. Smith, and P.L. Iversen HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers Antisense Nucleic Acid Drug Dev. 13 2003 31 43
122. S.W. Muchmore, M. Sattler, H. Liang, R.P. Meadows, and J.E. Harlan X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death Nature 381 1996 335 341
123. H. Nagahara, A.M. Vocero-Akbani, E.L. Snyder, A. Ho, D.G. Latham, N.A. Lissy, M. Becker-Hapak, S.A. Ezhevsky, and S.F. Dowdy Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration Nat. Med. 4 1998 1449 1452
124. I. Nakase, M. Niwa, T. Takeuchi, K. Sonomura, and N. Kawabata Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement Mol. Ther. 10 2004 1011 1022
125. B. Onteniente Natural and synthetic inhibitors of caspases: targets for novel drugs Curr. Drug Targets CNS Neurol. Disord. 3 2004 333 340
126. W.M. Pardridge Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins Adv. Exp. Med. Biol. 513 2002 397 430
127. W.M. Pardridge Blood-brain barrier drug targeting: the future of brain drug development Mol. Intervent. 3 2003 90 105
128. W.M. Pardridge Intravenous, non-viral RNAi gene therapy of brain cancer Expert Opin. Biol. Ther. 4 2004 1103 1113
129. L. Park, J. Anrather, P. Zhou, K. Frys, G. Wang, and C. Iadecola Exogenous NADPH increases cerebral blood flow through NADPH oxidase-dependent and -independent mechanisms Arterioscler. Thromb. Vasc. Biol. 24 2004 1860 1865
130. M. Peitz, K. Pfannkuche, K. Rajewsky, and F. Edenhofer Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes Proc. Natl. Acad. Sci. U.S.A. 99 2002 4489 4494
131. T. Peng, Y.H. Liu, C.L. Yang, C.M. Wan, Y.Q. Wang, and Z.R. Wang A new peptide with membrane-permeable function derived from human circadian proteins Acta Biochim. Biophys. Sin. (Shanghai) 36 2004 629 636
132. S.E. Perea, O. Reyes, Y. Puchades, O. Mendoza, and N.S. Vispo Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2) Cancer Res. 64 2004 7127 7129
133. F. Perez, A. Joliot, E. Bloch-Gallego, A. Zahraoui, A. Triller, and A. Prochiantz Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide J. Cell Sci. 102 1992 717 722
134. D. Persson, P.E. Thoren, M. Herner, P. Lincoln, and B. Nordén Application of a novel analysis to measure the binding of the membrane-translocating Peptide penetratin to negatively charged liposomes Biochemistry 42 2003 421 429
135. W. Pham, M.F. Kircher, R. Weissleder, and C.H. Tung Enhancing membrane permeability by fatty acylation of oligoarginine peptides Chembiochem 5 2004 1148 1151
136. M. Pizzi, I. Sarnico, F. Boroni, M. Benarese, and N. Steimberg NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity Cell Death Differ. 12 2005 761 772
137. M. Pooga, M. Hallbrink, M. Zorko, and U. Langel Cell penetration by transportan FASEB J. 12 1998 67 77
138. M. Pooga, U. Soomets, M. Hallbrink, A. Valkna, and K. Saar Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo Nat. Biotechnol. 16 1998 857 861
139. T.B. Potocky, A.K. Menon, and S.H. Gellman Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells J. Biol. Chem. 278 2003 50188 50194 (Epub 2003 Sep 29)
140. M.A. Prendergast, D.T. Rogers, P.J. Mulholland, J.M. Littleton, L.H. Wilkins Jr., R.L. Self, and A. Nath Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor. Brain Res. 954 2002 300 307
141. A. Prochiantz Peptide nucleic acid smugglers Nat. Biotechnol. 16 1998 819 820
142. A. Prochiantz Homeodomain-derived peptides. In and out of the cells Ann. N. Y. Acad. Sci. 886 1999 172 179
143. A. Prochiantz Messenger proteins: homeoproteins, TAT and others Curr. Opin. Cell Biol. 12 2000 400 406
144. Z.H. Qin, Y. Wang, M. Nakai, and T.N. Chase Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum Mol. Pharmacol. 53 1998 33 42
145. S.A. Reis, R. Willemsen, L. van Unen, A.T. Hoogeveen, and B.A. Oostra Prospects of TAT-mediated protein therapy for fragile X syndrome J. Mol. Histol. 35 2004 389 395
146. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, and B. Lebleu Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278 2003 585 590
147. M.F. Ross, A. Filipovska, R.A. Smith, M.J. Gait, and M.P. Murphy Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers Biochem. J. 383 2004 457 468
148. M.F. Ross, and M.P. Murphy Cell-penetrating peptides are excluded from the mitochondrial matrix Biochem. Soc. Trans. 32 2004 1072 1074
149. C. Rousselle, P. Clair, J.M. Lefauconnier, M. Kaczorek, J.M. Scherrmann, and J. Temsamani New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy Mol. Pharmacol. 57 2000 679 686
150. C. Rousselle, P. Clair, J. Temsamani, and J.M. Scherrmann Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy J. Drug Target 10 2002 309 315
151. C. Rousselle, M. Smirnova, P. Clair, J.M. Lefauconnier, A. Chavanieu, B. Calas, J.M. Scherrmann, and J. Temsamani Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity J. Pharmacol. Exp. Ther. 296 2001 124 131
152. P. Saalik, A. Elmquist, M. Hansen, K. Padari, K. Saar, K. Viht, U. Langel, and M. Pooga Protein cargo delivery properties of cell-penetrating peptides. A comparative study Bioconjug. Chem. 15 2004 1246 1253
153. J.M. Sabatier, E. Vives, K. Mabrouk, A. Benjouad, H. Rochat, A. Duval, B. Hue, and E. Bahraoui Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1 J. Virol. 65 1991 961 967
154. J.L. Saffell, E.J. Williams, I.J. Mason, F.S. Walsh, and P. Doherty Expression of a dominant negative FGF receptor inhibits axonal growth and FGF receptor phosphorylation stimulated by CAMs Neuron 18 1997 231 242
155. H. Sariola, and M. Saarma Novel functions and signalling pathways for GDNF J. Cell Sci. 116 2003 3855 3862
156. R. Sattler, and M. Tymianski Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death Mol. Neurobiol. 24 2001 107 129
157. A. Scheller, J. Oehlke, B. Wiesner, M. Dathe, E. Krause, M. Beyermann, M. Melzig, and M. Bienert Structural requirements for cellular uptake of alpha-helical amphipathic peptides J. Pept. Sci. 5 1999 185 194
158. A.D. Schimmer, D.W. Hedley, S. Chow, N.A. Pham, A. Chakrabartty, D. Bouchard, T.W. Mak, M.R. Trus, and M.D. Minden The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2 Cell Death Differ. 8 2001 725 733
159. F. Schlachetzki, Y. Zhang, R.J. Boado, and W.M. Pardridge Gene therapy of the brain: the trans-vascular approach Neurology 62 2004 1275 1281
160. S.R. Schwarze, A. Ho, A. Vocero-Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1999 1569 1572
161. T. Sengoku, V. Bondada, D. Hassane, S. Dubal, and J.W. Geddes Tat-calpastatin fusion proteins transduce primary rat cortical neurons but do not inhibit cellular calpain activity Exp. Neurol. 188 2004 161 170
162. K. Si, M. Giustetto, A. Etkin, R. Hsu, A.M. Janisiewicz, M.C. Miniaci, J.H. Kim, H. Zhu, and E.R. Kandel A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in Aplysia Cell 115 2003 893 904
163. M. Silhol, M. Tyagi, M. Giacca, B. Lebleu, and E. Vives Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat Eur. J. Biochem. 269 2002 494 501
164. J.J. Skehel, K. Cross, D. Steinhauer, and D.C. Wiley Influenza fusion peptides Biochem. Soc. Trans. 29 2001 623 626
165. E.L. Snyder, B.R. Meade, C.C. Saenz, and S.F. Dowdy Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide PLoS Biol. 2 2004 E36 (Epub 2004 Feb 17)
166. L. Soane, L.L. Bambrick, G. Fiskum, Tat-mediated intracellular delivery of the loop deletion Bcl-2 protein protects neurons against cell death, Abstract Viewer/Itinerary Planner, Society for Neuroscience Program No. 687.3,Washington, DC, 2004.
167. L. Song, A. Nath, J. Geiger, A. Moore, and S. Hochman Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-d-aspartate receptors at an Allosteric zinc-sensitive site J. Neurovirol. 9 2003 399 403
168. B.W. Song, H.V. Vinters, D. Wu, and W.M. Pardridge Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector J. Pharmacol. Exp. Ther. 301 2002 605 610
169. T. Suzuki, S. Futaki, M. Niwa, S. Tanaka, K. Ueda, and Y. Sugiura Possible existence of common internalization mechanisms among arginine-rich peptides J. Biol. Chem. 277 2002 2437 2443
170. S.M. Sweitzer, S.M. Wong, M.C. Peters, D. Mochly-Rosen, D.C. Yeomans, and J.J. Kendig Protein kinase C epsilon and gamma: involvement in formalin-induced nociception in neonatal rats J. Pharmacol. Exp. Ther. 309 2004 616 625 (Epub 2004 Feb 04)
171. S.M. Sweitzer, S.M. Wong, A. Tjolsen, C.P. Allen, D. Mochly-Rosen, and J.J. Kendig Exaggerated nociceptive responses on morphine withdrawal: roles of protein kinase C epsilon and gamma Pain 110 2004 281 289
172. K. Tahara, D. Tsuchimoto, Y. Tominaga, S. Asoh, S. Ohta, M. Kitagawa, H. Horie, T. Kadoya, and Y. Nakabeppu DeltaFosB, but not FosB, induces delayed apoptosis independent of cell proliferation in the Rat1a embryo cell line Cell Death Differ. 10 2003 496 507
173. L. Theodore, D. Derossi, G. Chassaing, B. Llirbat, M. Kubes, P. Jordan, H. Chneiweiss, P. Godement, and A. Prochiantz Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse J. Neurosci. 15 1995 7158 7167
174. P.E. Thorén, D. Persson, M. Karlsson, and B. Nordén The Antennapedia peptide penetratin translocates across lipid bilayers - the first direct observation FEBS Lett. 482 2000 265 268
175. V.P. Torchilin, and A.N. Lukyanov Peptide and protein drug delivery to and into tumors: challenges and solutions Drug Discov. Today 8 2003 259 266
176. T.R. Torgerson, A.D. Colosia, J.P. Donahue, Y.Z. Lin, and J. Hawiger Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50 J. Immunol. 161 1998 6084 6092
177. C.M. Troy, L. Stefanis, A. Prochiantz, L.A. Greene, and M.L. Shelanski The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation Proc. Natl. Acad. Sci. U.S.A. 93 1996 5635 5640
178. M. van de Bovenkamp, H.S. Nottet, and C.F. Pereira Interactions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1-associated dementia Eur. J. Clin. Invest. 32 2002 619 627
179. J. Vazquez, C. Sun, J. Du, L. Fuentes, C. Sumners, and M.K. Raizada Transduction of a functional domain of the AT1 receptor in neurons by HIV-Tat PTD Hypertension 41 2003 751 756
180. E. Vives, P. Brodin, and B. Lebleu A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 272 1997 16010 16017
181. J.S. Wadia, R.V. Stan, and S.F. Dowdy Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 10 2004 310 315
182. T. Waizenegger, R. Fischer, and R. Brock Intracellular concentration measurements in adherent cells: a comparison of import efficiencies of cell-permeable peptides Biol. Chem. 383 2002 291 299
183. L.D. Walensky, A.L. Kung, I. Escher, T.J. Malia, S. Barbuto, R.D. Wright, G. Wagner, G.L. Verdine, and S.J. Korsmeyer Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix Science 305 2004 1466 1470
184. J.H. Weishaupt, and M. Bähr Degeneration of axotomized retinal ganglion cells as a model for neuronal apoptosis in the central nervous system-molecular death and survival pathways Restor. Neurol. Neurosci. 19 2001 19 27
185. P.A. Wender, D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman, and J.B. Rothbard The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U.S.A. 97 2000 13003 13008
186. E.J. Williams, and P. Doherty Evidence for and against a pivotal role of PI 3-kinase in a neuronal cell survival pathway Mol. Cell Neurosci. 13 1999 272 280
187. M.J. Winton, C.I. Dubreuil, R.B. Campenot, L. McKerracher, The effects of C3-05 treatment on sympathetic neurons plated in Campenot chambers, Abstract Viewer/Itinerary Planner, Society for Neuroscience (2003) Program No. 678.7, Washington, DC.
188. D. Wu, B.W. Song, H.V. Vinters, and W.M. Pardridge Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system J. Drug Target 10 2002 239 245
189. H.Y. Wu, K. Tomizawa, M. Matsushita, Y.F. Lu, S.T. Li, and H. Matsui Poly-arginine-fused calpastatin peptide, a living cell membrane-permeable and specific inhibitor for calpain Neurosci. Res. 47 2003 131 135
190. H. Xia, Q. Mao, and B.L. Davidson The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors Nat. Biotechnol. 19 2001 640 644
191. 2+-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons J. Neurosci. 24 2004 10846 10857
192. H.Y. Yeung, D.K. Chan, N.K. Mak, G.F. Wagner, and C.K. Wong Identification of signal transduction pathways that modulate dibutyryl cyclic adenosine monophosphate activation of stanniocalcin gene expression in neuroblastoma cells Endocrinology 144 2003 4446 4452
193. H.Y. Yoon, S.H. Lee, S.W. Cho, J.E. Lee, C.S. Yoon, J. Park, T.U. Kim, and S.Y. Choi TAT-mediated delivery of human glutamate dehydrogenase into PC12 cells Neurochem. Int. 41 2002 37 42
194. M.B. Youdim, and J.J. Buccafusco Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders Trends Pharmacol. Sci. 26 2005 27 35
195. J.L. Zaro, and W.C. Shen Quantitative comparison of membrane transduction and endocytosis of oligopeptides Biochem. Biophys. Res. Commun. 307 2003 241 247
196. J. Zezula, P. Casaccia-Bonnefil, S.A. Ezhevsky, D.J. Osterhout, J.M. Levine, S.F. Dowdy, M.V. Chao, and A. Koff p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal EMBO Rep. 2 2001 27 34
197. Y. Zhang, F. Calon, C. Zhu, R.J. Boado, and W.M. Pardridge Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism Hum. Gene Ther. 14 2003 1 12
198. Y. Zhang, F. Schlachetzki, and W.M. Pardridge Global non-viral gene transfer to the primate brain following intravenous administration Mol. Ther. 7 2003 11 18
199. C. Zhu, Y. Zhang, and W.M. Pardridge Widespread expression of an exogenous gene in the eye after intravenous administration Invest. Ophthalmol. Vis. Sci. 43 2002 3075 3080
200. A. Ziegler, P. Nervi, M. Durrenberger, and J. Seelig The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence Biochemistry 44 2005 138 148
201. A. Ziegler, and J. Seelig Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters Biophys. J. 86 2004 254 263